{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T16:28:21Z","timestamp":1743784101896,"version":"3.37.3"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T00:00:00Z","timestamp":1704499200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T00:00:00Z","timestamp":1704499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004257","name":"Helse Vest","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004257","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Bergen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This protocol paper presents an updated statistical analysis plan of the protocol of a randomised controlled trial. The randomised controlled trial investigates the effect of integrating smoking cessation interventions at outpatient opioid agonist therapy (OAT) clinics for persons with opioid dependency receiving OAT medication. The intervention group receives weekly follow-up including a short behavioural intervention and provision of nicotine replacement products. The control group receives standard treatment. The duration of the intervention is 16 weeks and the follow-up was completed by the end of October 2023. The primary outcome is defined as the proportion of participants reducing the number of cigarettes smoked by at least a 50% at week 16 of the intervention period. The primary outcome will be analysed according to intention-to-treat principles. Missing outcome data will be set equal to the baseline values. Development and reporting of the statistical analysis plan follow the Guidelines for the Content of Statistical Analysis Plans in Clinical Trials.<\/jats:p><jats:p><jats:bold>Trial registration<\/jats:bold> ClinicalTrials.gov NCT05290025. Registered on 22 March 2022.<\/jats:p>","DOI":"10.1186\/s13063-023-07894-w","type":"journal-article","created":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T05:01:59Z","timestamp":1704517319000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Update of statistical analysis plan for: Integration of smoking cessation into standard treatment for patients receiving opioid agonist therapy who are smoking tobacco: protocol for a randomised controlled trial (ATLAS4LAR)"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2905-0613","authenticated-orcid":false,"given":"Karl Trygve","family":"Druckrey-Fiskaaen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tesfaye","family":"Madebo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan Tore","family":"Daltveit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f8rn Henrik","family":"Vold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Einar","family":"Furulund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torgeir Gilje","family":"Lid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars Thore","family":"Fadnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,6]]},"reference":[{"issue":"23","key":"7894_CR1","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1001\/jama.2017.18556","volume":"318","author":"C Gamble","year":"2017","unstructured":"Gamble C, Krishan A, Stocken D, Lewis S, Juszczak E, Dor\u00e9 C, et al. Guidelines for the content of statistical analysis plans in clinical trials. JAMA. 2017;318(23):2337\u201343.","journal-title":"JAMA"},{"issue":"2","key":"7894_CR2","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/add.13099","volume":"111","author":"J Guydish","year":"2016","unstructured":"Guydish J, Passalacqua E, Pagano A, Martinez C, Le T, Chun J, et al. An international systematic review of smoking prevalence in addiction treatment. Addiction. 2016;111(2):220\u201330.","journal-title":"Addiction"},{"issue":"4","key":"7894_CR3","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s40263-020-00701-z","volume":"34","author":"C Vlad","year":"2020","unstructured":"Vlad C, Arnsten JH, Nahvi S. Achieving smoking cessation among persons with opioid use disorder. CNS Drugs. 2020;34(4):367\u201387.","journal-title":"CNS Drugs"},{"issue":"4","key":"7894_CR4","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s11414-020-09712-6","volume":"47","author":"CD Morris","year":"2020","unstructured":"Morris CD, Garver-Apgar CE. Nicotine and opioids: a call for co-treatment as the standard of care. J Behav Health Serv Res. 2020;47(4):601\u201313.","journal-title":"J Behav Health Serv Res"},{"issue":"6","key":"7894_CR5","doi-asserted-by":"publisher","first-page":"e1003653","DOI":"10.1371\/journal.pmed.1003653","volume":"18","author":"LT Fadnes","year":"2021","unstructured":"Fadnes LT, Aas CF, Vold JH, Leiva RA, Ohldieck C, Chalabianloo F, et al. Integrated treatment of hepatitis C virus infection among people who inject drugs: a multicenter randomized controlled trial (INTRO-HCV). PLoS Med. 2021;18(6):e1003653.","journal-title":"PLoS Med"},{"issue":"1","key":"7894_CR6","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1186\/s13063-022-06560-x","volume":"23","author":"KT Druckrey-Fiskaaen","year":"2022","unstructured":"Druckrey-Fiskaaen KT, Furulund E, Daltveit JT, Vold JH, Lid TG, Madebo T, Fadnes LT. Integration of smoking cessation into standard treatment for patients receiving opioid agonist therapy who are smoking tobacco: protocol for a randomised controlled trial (ATLAS4LAR). Trials. 2022;23(1):663.","journal-title":"Trials"},{"key":"7894_CR7","doi-asserted-by":"publisher","first-page":"g7327","DOI":"10.1136\/bmj.g7327","volume":"349","author":"P Sedgwick","year":"2014","unstructured":"Sedgwick P. Spearman\u2019s rank correlation coefficient. BMJ. 2014;349:g7327.","journal-title":"BMJ"},{"key":"7894_CR8","unstructured":"European Medicines Agency CfHMP. Guideline for good clinical practice E6(R2). 6 ed. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/ich-e-6-r2-guideline-good-clinical-practice-step-5_en.pdf2018."},{"key":"7894_CR9","unstructured":"Development OfEC-oa. OECD Principles on Good Laboratory Practice. In: DIRECTORATE E, COMMITTEE CGAM, editors. https:\/\/www.oecd.org\/officialdocuments\/publicdisplaydocumentpdf\/?cote=env\/mc\/chem(98)17&doclanguage=en1998."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07894-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-023-07894-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07894-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,7]],"date-time":"2024-01-07T21:12:27Z","timestamp":1704661947000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-023-07894-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,6]]},"references-count":9,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["7894"],"URL":"https:\/\/doi.org\/10.1186\/s13063-023-07894-w","relation":{},"ISSN":["1745-6215"],"issn-type":[{"type":"electronic","value":"1745-6215"}],"subject":[],"published":{"date-parts":[[2024,1,6]]},"assertion":[{"value":"12 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Except from use of a few hours of time from the participants and some examinations such as blood sample collection can be regarded as unpleasant, participation is not believed to be linked with substantial risks. The study has been approved by regional ethical committee (no. 155386\/REK S\u00f8r-\u00f8st -B, dated 23 September 2020\/03 December 2021\/05 April 2022). The trial will be conducted in strict accordance with the Declaration of Helsinki and other international conventions and with good clinical practice and good laboratory practice [, ]. Written informed consent and assent will be obtained from each participant.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable\u2014no identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results. Informed consent materials are available from the corresponding author on request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29"}}